Business
Chimeric (ASX:CHM) share price drops despite cancer trial update
Image Source: Getty Images
The Chimeric Therapeutics Ltd (ASX: CHM) share price has fallen today. It coincides with the drug development company’s update on its cancer cell therapy.
At market’s close, the Chimeric share price was trading at 29 cents, down…
Continue Reading